Pontifax Late Stage Gp Ltd. - Net Worth and Insider Trading

Pontifax Late Stage Gp Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pontifax Late Stage Gp Ltd. owns 2 companies in total, including Keros Therapeutics Inc (KROS) , and 89bio Inc (ETNB) .

Click here to see the complete history of Pontifax Late Stage Gp Ltd.’s form 4 insider trades.

Insider Ownership Summary of Pontifax Late Stage Gp Ltd.

Ticker Comapny Transaction Date Type of Owner
KROS Keros Therapeutics Inc 2020-04-07 10 percent owner
ETNB 89bio Inc 2019-11-11 10 percent owner

Pontifax Late Stage Gp Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Pontifax Late Stage Gp Ltd. Ownership Network

Ownership Network List of Pontifax Late Stage Gp Ltd.

No Data

Ownership Network Relation of Pontifax Late Stage Gp Ltd.

Insider Network Chart

Pontifax Late Stage Gp Ltd. Owned Company Details

What does Keros Therapeutics Inc do?

Who are the key executives at Keros Therapeutics Inc?

Pontifax Late Stage Gp Ltd. is the 10 percent owner of Keros Therapeutics Inc. Other key executives at Keros Therapeutics Inc include Chief Financial Officer Keith Regnante , Chief Scientific Officer Jennifer Lachey , and Chief Operating Officer Christopher Rovaldi .

Keros Therapeutics Inc (KROS) Insider Trades Summary

Over the past 18 months, Pontifax Late Stage Gp Ltd. made no insider transaction in Keros Therapeutics Inc (KROS). Other recent insider transactions involving Keros Therapeutics Inc (KROS) include a net sale of 80,000 shares made by Keith Regnante , a net sale of 250,000 shares made by Orbimed Advisors Llc , and a net sale of 250,000 shares made by Carl L Gordon .

In summary, during the past 3 months, insiders sold 500,000 shares of Keros Therapeutics Inc (KROS) in total and bought 0 shares, with a net sale of 500,000 shares. During the past 18 months, 580,000 shares of Keros Therapeutics Inc (KROS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 580,000 shares.

Keros Therapeutics Inc (KROS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Keros Therapeutics Inc Insider Transactions

No Available Data

Pontifax Late Stage Gp Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Pontifax Late Stage Gp Ltd.. You might contact Pontifax Late Stage Gp Ltd. via mailing address: 14 Shenkar Street, Beit Ofek, Herzliya Pituach L3 L3 46140.

Discussions on Pontifax Late Stage Gp Ltd.

No discussions yet.